Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Sherman

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 28, 2007
Management of chronic hepatitis C: consensus guidelinesMorris Sherman, Stephen Shafran, Kelly Burak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2007
HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patientsSaira S Mohammed, Elaheh Aghdassi, Irving E Salit, et al.
Canadian Liver Journal|August 22, 2022
Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trialEdward Tam, Sergio Borgia, Eric M Yoshida, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|March 30, 2013
Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamineBianca M Arendt, David W L Ma, Brigitte Simons, et al.
Canadian Journal of Gastroenterology & Hepatology|July 22, 2015
Time to make the change from 'primary biliary cirrhosis' to 'primary biliary cholangitis'Angela C Cheung, Aldo Montano-Loza, Mark Swain, et al.
Canadian Journal of Gastroenterology & Hepatology|May 20, 2014
Burden of disease and cost of chronic hepatitis C infection in CanadaRobert P Myers, Mel Krajden, Marc Bilodeau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2008
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinomaRichard K Sterling, Lennox Jeffers, Fredric Gordon, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|December 26, 2002
Radiofrequency ablation of malignant hepatic neoplasmsRaymond P Chan, Murray Asch, John Kachura, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Outcomes of chronic hepatitis C therapy in patients treated in community versus academic centres in Canada: final results of APPROACH (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in Canada)Robert P Myers, Curtis Cooper, Morris Sherman, et al.
AJR. American Journal of Roentgenology|February 26, 2015
Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid)Kartik Jhaveri, Sean Cleary, Pascale Audet, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 28, 2007
Management of chronic hepatitis C: consensus guidelinesMorris Sherman, Stephen Shafran, Kelly Burak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2007
HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patientsSaira S Mohammed, Elaheh Aghdassi, Irving E Salit, et al.
Canadian Liver Journal|August 22, 2022
Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trialEdward Tam, Sergio Borgia, Eric M Yoshida, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|March 30, 2013
Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamineBianca M Arendt, David W L Ma, Brigitte Simons, et al.
Canadian Journal of Gastroenterology & Hepatology|July 22, 2015
Time to make the change from 'primary biliary cirrhosis' to 'primary biliary cholangitis'Angela C Cheung, Aldo Montano-Loza, Mark Swain, et al.
Canadian Journal of Gastroenterology & Hepatology|May 20, 2014
Burden of disease and cost of chronic hepatitis C infection in CanadaRobert P Myers, Mel Krajden, Marc Bilodeau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2008
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinomaRichard K Sterling, Lennox Jeffers, Fredric Gordon, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|December 26, 2002
Radiofrequency ablation of malignant hepatic neoplasmsRaymond P Chan, Murray Asch, John Kachura, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Outcomes of chronic hepatitis C therapy in patients treated in community versus academic centres in Canada: final results of APPROACH (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in Canada)Robert P Myers, Curtis Cooper, Morris Sherman, et al.
AJR. American Journal of Roentgenology|February 26, 2015
Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid)Kartik Jhaveri, Sean Cleary, Pascale Audet, et al.
Pageof 16